|
![]() |
|||
|
||||
OverviewThis book provides a collection of comprehensive, up-to-date, and broadly applicable guides to the research and development fields of oligonucleotide (ON) therapeutics. Covering topics from the study of antisense and anti-gene effects to oligonucleotides in the context of drug discovery and development, the volume explores a wide-ranging and useful spectrum of methods and protocols needed to take full advantage of therapeutic applications involving ONs. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Oligonucleotide-Based Therapies: Methods and Protocols aims to be a great aid in the laboratory as well as an ideal reference guide when designing antisense and anti-gene oligonucleotides for therapeutic applications. Full Product DetailsAuthor: Olof Gissberg , Rula Zain , Karin E. LundinPublisher: Humana Press Inc. Imprint: Humana Press Inc. Edition: 1st ed. 2019 Volume: 2036 Weight: 0.677kg ISBN: 9781493996728ISBN 10: 149399672 Pages: 344 Publication Date: 15 August 2020 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsPart I: Reviews 1. Chemical Development of Therapeutic Oligonucleotides Karin E. Lundin, Olof Gissberg, C.I. Edvard Smith, and Rula Zain 2. Tissue-Specific Delivery of Oligonucleotides Xin Xia, Nicolette Pollock, Jiehua Zhou, and John Rossi Part II: Protocols and Strategies 3. Designing siRNA and Evaluating Its Effect on RNA Targets Using qPCR and Western Blot Linda Vidarsdottir, Oksana Goroshchuk, Iryna Kolosenko, and Caroline Palm-Apergi 4. Antisense Oligonucleotides for Splice Modulation: Assessing Splice Switching Efficacy Cristina S.J. Rocha 5. Assessing Oligonucleotide Binding to Double-Strand DNA Negin Mozafari and Tea Umek 6. Modelling and Simulation of Oligonucleotide Hybrids: Outlining a Strategy Lennart Nilsson and Alessandra Villa 7. Characterization of Peptide/Oligonucleotide Complexes Using Electron Microscopy, Dynamic Light Scattering, and Protease Resistance Assay Kärt Padari, Ly Porosk, Piret Arukuusk, and Margus Pooga 8. Click-Shielded and Targeted Lipopolyplexes Philipp Michael Klein and Ernst Wagner 9. Attachment of Peptides to Oligonucleotides on Solid Support Using Copper(I)-Catalyzed Huisgen 1,3-Dipolar Cycloaddition Malgorzata Honcharenko, Dmytro Honcharenko, and Roger Stromberg 10. Characterizing Oligonucleotide Uptake in Cultured Cells: A Case Study Using AS1411 Aptamer Elsa M. Reyes-Reyes and Paula J. Bates 11. Measuring the Action of Oligonucleotide Therapeutics in the Lung at the Cell Type-Specific Level by Tissue Disruption and Cell Sorting (TDCS) Helen Graves, Steven Evans, Michael Fauler, Manfred Frick, and Sterghios A. Moschos 12. Delivery of Antisense Oligonucleotides Mediated by a Hydrogel System: In Vitro and In Vivo Application in the Context of Spinal Cord Injury Pedro M.D. Moreno, Teresa Rodrigues, Marília Torrado, Isabel F. Amaral, and Ana P. Pêgo 13. Evaluation of Cell-Penetrating Peptide Delivery of Antisense Oligonucleotides for Therapeutic Efficacy in Spinal Muscular Atrophy Suzan M. Hammond, Frank Abendroth, Michael J. Gait, and Matthew J.A. Wood 14. Injection and Infusion of Compounds to the Central Nervous System Margherita Zamboni 15. In Vitro Assessment of the Hepatotoxicity Potential of Therapeutic Oligonucleotides Sabine Sewing, Tanja Minz, and Franziska Boess 16. Identifying Suitable Target Regions and Analyzing Off-Target Effects Lykke Pedersen, Peter H. Hagedorn, and Troels Koch 17. RACE-SEQ and Population-Wide Polymorphism Susceptibility Testing for Endonucleolytically Active, RNA-Targeting Therapeutics Louise Usher, Pantazis I. Theotokis, and Sterghios A. Moschos 18. Studying the Biotransformation of Phosphorothioate-Containing Oligonucleotide Drugs by LC-MS Christophe Husser, Erich Koller, Andreas Brink, and Simone Schadt 19. ADME: Assessing Pharmacokinetic-Pharmacodynamic Parameters of Oligonucleotides Rasmus Jansson-Löfmark*, Christine Ahlström, and Peter GennemarkReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |